These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 22037588)

  • 1. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
    Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
    Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
    Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
    Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
    Calkins MJ; Reddy PH
    Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
    Manczak M; Calkins MJ; Reddy PH
    Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.
    Du H; Guo L; Yan S; Sosunov AA; McKhann GM; Yan SS
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18670-5. PubMed ID: 20937894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
    Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.
    Manczak M; Mao P; Calkins MJ; Cornea A; Reddy AP; Murphy MP; Szeto HH; Park B; Reddy PH
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S609-31. PubMed ID: 20463406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease.
    Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Kandimalla R; Kuruva CS
    J Investig Med; 2016 Dec; 64(8):1220-1234. PubMed ID: 27521081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.
    Reddy AP; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():173-201. PubMed ID: 28253985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
    Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
    Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
    Reddy PH
    Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.
    Reddy AP; Yin X; Sawant N; Reddy PH
    Hum Mol Genet; 2021 May; 30(10):847-864. PubMed ID: 33615359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
    Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
    Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice.
    Jia YL; Sun SJ; Chen JH; Jia Q; Huo TT; Chu LF; Bai JT; Yu YJ; Yan XX; Wang JH
    Curr Alzheimer Res; 2016; 13(3):297-306. PubMed ID: 26679857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.